Index S&P 500 P/E 12.41 EPS (ttm) 20.34 Insider Own 27.23% Shs Outstand 277.38M Perf Week 0.07%
Market Cap 67.55B Forward P/E 12.90 EPS next Y 19.56 Insider Trans -0.01% Shs Float 194.78M Perf Month 11.98%
Income 5.72B PEG 1.42 EPS next Q 5.05 Inst Own 64.79% Short Float / Ratio 1.28% / 1.79 Perf Quarter -10.13%
Sales 63.16B P/S 1.07 EPS this Y 7.83% Inst Trans -2.48% Short Interest 2.50M Perf Half Y -7.99%
Book/sh -9.21 P/B - EPS next Y 7.43% ROA 10.78% Target Price 281.72 Perf Year 5.05%
Cash/sh 3.71 P/C 67.95 EPS next 5Y 8.76% ROE - 52W Range 215.96 - 304.86 Perf YTD 5.17%
Dividend 2.39 P/FCF 15.44 EPS past 5Y 26.32% ROI 15.84% 52W High -17.22% Beta 1.64
Dividend % 0.95% Quick Ratio 0.99 Sales past 5Y 6.78% Gross Margin 14.63% 52W Low 16.85% ATR 5.23
Employees 294000 Current Ratio 1.15 Sales Q/Q 8.30% Oper. Margin 14.63% RSI (14) 62.52 Volatility 1.49% 2.05%
Optionable Yes Debt/Eq - EPS Q/Q 0.14% Profit Margin 9.05% Rel Volume 0.70 Prev Close 250.48
Shortable Yes LT Debt/Eq - Earnings Oct 24 BMO Payout 11.70% Avg Volume 1.39M Price 252.36
Recom 1.45 SMA20 4.93% SMA50 4.84% SMA200 -4.50% Volume 976,256 Change 0.75%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated Loop Capital
Buy
$240
May-27-22 Upgrade Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed Citigroup
Buy
$274 → $306
Dec-21-21 Downgrade JP Morgan
Overweight → Neutral
$270
Sep-27-21 Initiated SVB Leerink
Outperform
$320
Sep-24-21 Initiated UBS
Buy
$312
Sep-10-21 Initiated Cowen
Outperform
$293
Aug-12-21 Downgrade Barclays
Overweight → Equal Weight
$275 → $267
Jul-09-21 Initiated Seaport Global Securities
Buy
$235
May-13-21 Resumed Citigroup
Neutral
$215
Apr-26-21 Downgrade Citigroup
Buy → Neutral
$191 → $215
Dec-15-20 Initiated Goldman
Buy
$191
Dec-14-20 Upgrade JP Morgan
Neutral → Overweight
$194
Sep-21-20 Downgrade JP Morgan
Overweight → Neutral
$161 → $143
Jul-13-20 Downgrade BMO Capital Markets
Outperform → Market Perform
$100
Sep-06-19 Upgrade BofA/Merrill
Underperform → Neutral
$130 → $137
Show Previous Ratings
Dec-01-23 09:00AM
Nov-28-23 09:30AM
Nov-25-23 07:00AM
Nov-23-23 11:30AM
Nov-21-23 01:01PM
07:00AM
Loading…
07:00AM
06:45AM
Nov-20-23 05:58PM
Nov-13-23 11:40AM
08:30AM
Nov-10-23 05:36AM
Nov-09-23 07:30AM
Nov-06-23 04:30PM
Nov-02-23 09:00AM
06:17AM
08:30AM
Loading…
Nov-01-23 08:30AM
Oct-29-23 05:35PM
Oct-27-23 04:28PM
12:08PM
Oct-26-23 04:30PM
Oct-25-23 10:57AM
04:15AM
12:45AM
(Thomson Reuters StreetEvents)
Oct-24-23 05:00PM
04:52PM
12:23PM
12:11PM
12:03PM
11:57AM
11:35AM
10:52AM
Loading…
10:52AM
10:12AM
10:11AM
09:30AM
08:47AM
08:40AM
07:56AM
07:46AM
07:43AM
07:38AM
(Associated Press Finance)
07:36AM
07:30AM
Oct-22-23 04:26PM
Oct-19-23 05:45PM
01:16PM
Oct-18-23 10:01AM
Oct-17-23 11:03AM
10:00AM
08:30AM
Oct-15-23 07:10AM
Oct-13-23 05:45PM
07:41AM
Oct-12-23 08:30AM
Oct-11-23 12:24PM
Oct-10-23 04:30PM
12:54PM
11:00AM
10:00AM
(The Wall Street Journal)
Oct-04-23 05:45PM
08:30AM
Oct-03-23 04:58PM
04:58AM
Oct-02-23 11:29AM
Sep-29-23 02:10PM
01:02PM
11:34AM
Sep-28-23 08:30AM
Sep-27-23 05:45PM
Sep-25-23 04:39PM
(American City Business Journals)
04:39PM
(American City Business Journals)
12:47PM
Sep-23-23 09:00AM
Sep-21-23 05:45PM
09:30AM
08:10AM
Sep-20-23 07:18AM
Sep-19-23 01:05PM
(American City Business Journals)
11:09AM
08:30AM
08:11AM
07:35AM
(American City Business Journals)
Sep-18-23 12:20PM
09:40AM
Sep-15-23 12:03PM
11:36AM
08:30AM
07:14AM
04:36AM
Sep-14-23 05:45PM
01:35PM
01:07PM
09:00AM
08:27AM
Sep-13-23 01:26PM
Sep-12-23 10:56AM
Sep-11-23 11:45AM
Sep-06-23 05:45PM
11:21AM
11:13AM
Sep-05-23 12:45PM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Akdamar Erol R Group President Nov 13 Option Exercise 47.97 26,825 1,286,795 26,825 Nov 15 05:37 PM Torres Kathryn A. SVP-Payer Contracting & Align. Aug 14 Sale 269.12 5,204 1,400,516 19,760 Aug 16 05:12 PM Cohen Jeffrey E. SVP-Government Relations Aug 11 Sale 270.00 1,500 405,000 4,414 Aug 15 05:20 PM Whalen Kathleen M SVP & Chief Ethics Officer Aug 03 Sale 270.00 2,916 787,320 10,250 Aug 07 04:39 PM Torres Kathryn A. SVP-Payer Contracting & Align. Apr 28 Option Exercise 141.51 8,844 1,251,532 31,087 May 02 05:32 PM Cuffe Michael S. EVP and Chief Clinical Officer Apr 28 Sale 284.44 12,556 3,571,396 28,783 May 02 05:30 PM Akdamar Erol R Group President Apr 28 Sale 285.00 3,500 997,500 42,484 May 02 05:27 PM Cuffe Michael S. EVP and Chief Clinical Officer Apr 24 Option Exercise 101.16 32,020 3,239,143 60,803 Apr 26 04:54 PM Torres Kathryn A. SVP-Payer Contracting & Align. Apr 24 Sale 288.38 4,473 1,289,913 22,243 Apr 26 04:55 PM Paslick P. Martin SVP and CIO Apr 14 Sale 275.00 2,687 738,925 24,643 Apr 14 05:51 PM Paslick P. Martin SVP and CIO Apr 12 Option Exercise 81.96 6,340 519,626 30,983 Apr 14 05:51 PM Paslick P. Martin SVP and CIO Apr 10 Sale 270.00 2,539 685,530 24,643 Apr 12 06:23 PM Paslick P. Martin SVP and CIO Apr 05 Option Exercise 81.96 6,000 491,760 30,643 Apr 06 06:26 PM Paslick P. Martin SVP and CIO Apr 04 Sale 265.00 3,034 804,010 24,643 Apr 06 06:26 PM Whalen Kathleen M SVP & Chief Ethics Officer Feb 17 Sale 263.61 1,734 457,097 9,962 Feb 22 08:10 PM Torres Kathryn A. SVP-Payer Contracting & Align. Feb 16 Option Exercise 101.16 4,575 462,807 24,947 Feb 21 07:17 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 07 Sale 255.23 4,000 1,020,912 7,392 Feb 09 06:15 PM HAZEN SAMUEL N CEO Feb 03 Option Exercise 68.96 59,000 4,068,640 137,885 Feb 07 06:40 PM Akdamar Erol R Group President Feb 03 Option Exercise 45.30 9,000 407,700 43,726 Feb 06 06:05 PM RUTHERFORD BILL B CFO and EVP Feb 03 Sale 258.19 30,000 7,745,568 81,632 Feb 03 06:22 PM Reiner Deborah M SVP - Mktg. & Communications Feb 03 Sale 257.61 7,941 2,045,699 0 Feb 07 06:41 PM Akdamar Erol R Group President Feb 02 Sale 258.63 3,000 775,891 34,726 Feb 06 06:05 PM RUTHERFORD BILL B CFO and EVP Feb 01 Option Exercise 69.22 64,000 4,430,180 146,527 Feb 03 06:22 PM Foster Jon M EVP and COO Feb 01 Sale 251.98 16,424 4,138,480 10,938 Feb 01 07:57 PM Wyatt Christopher F. SVP & Controller Feb 01 Sale 253.30 4,900 1,241,170 32,392 Feb 01 08:08 PM Cuffe Michael S. EVP and Chief Clinical Officer Feb 01 Sale 257.11 4,000 1,028,440 20,823 Feb 01 07:57 PM Paslick P. Martin SVP and CIO Feb 01 Sale 256.95 1,000 256,949 3,000 Feb 01 08:03 PM Whalen Kathleen M SVP & Chief Ethics Officer Jan 31 Option Exercise 69.58 1,250 86,975 12,282 Feb 01 08:07 PM Foster Jon M EVP and COO Jan 30 Option Exercise 69.17 35,955 2,486,869 46,893 Feb 01 07:57 PM Wyatt Christopher F. SVP & Controller Jan 30 Option Exercise 81.96 12,000 983,520 44,184 Feb 01 08:08 PM McManus Timothy M Group President Jan 30 Sale 254.06 7,900 2,007,067 13,987 Feb 01 08:02 PM Paslick P. Martin SVP and CIO Jan 23 Option Exercise 81.96 6,000 491,760 25,112 Jan 25 07:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
